X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20221115006592/en/Alexion-AstraZeneca-Rare-Disease-Completes-Acquisition-of-LogicBio%C2%AE-Therapeutics
https://www.prnewswire.com/news-releases/logicbio-therapeutics-reports-third-quarter-2022-financial-results-and-provides-business-updates-301676349.html
https://www.prnewswire.com/news-releases/alexion-astrazeneca-rare-disease-to-acquire-logicbio-therapeutics-to-accelerate-growth-in-genomic-medicine-301638676.html
https://apnews.com/article/mlb-science-health-sports-genetics-56e237a81e32df89e5ab8fd77b7ff01d
https://www.prnewswire.com/news-releases/logicbio-therapeutics-announces-pre-clinical-results-for-mlb-001-published-in-peer-reviewed-journal-plos-one-301629249.html
https://www.prnewswire.com/news-releases/logicbio-therapeutics-reports-second-quarter-2022-financial-results-and-provides-corporate-update-301605458.html
https://www.prnewswire.com/news-releases/logicbio-therapeutics-reports-first-quarter-2022-financial-results-and-highlights-recent-business-updates-301547538.html
https://www.fiercebiotech.com/biotech/logicbios-sun-rises-again-after-fda-releases-clinical-hold-pediatric-genome-editing-therapy
https://www.fiercebiotech.com/biotech/fda-puts-logicbio-genome-editing-therapy-trial-hold-after-second-infant-suffers-adverse
Market Place
Share 
